🔗 Share this article Social Media Content Creators Driving Parallel Trade for Unapproved Slimming Drug An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings. Experimental Drug Acquiring Traction Online The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers. Active Trade on Social Networks Separately, a flourishing trade exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Vendors market the substance there before redirecting buyers to other platforms for purchases. Understanding The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic. Healthcare Professionals Express Worries Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin. Several experts said the demand for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro. Legal Status and Implementation Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations. Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer laws, risking penalties, prosecution or prison. Service Reaction and Content Removal Based on the social media company, the service has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the service safe and investing in enhancing compliance measures. Digital Marketplace Operations Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or injecting at home. Within minutes of entering one group, a seller posted contact information, where the majority of purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about weight, health issues or past usage. Item Details and Costs Inside these groups, posts display dark colored parcels with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.” Buyers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting responses varying between a few weeks to “depends on your body”. Service Oversight and Security Actions A representative for Telegram stated it regularly moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Expert Cautions “Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at a pharmacy service. A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said. Her staff has previously encountered individuals injured by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.” Producer Position A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose users to potentially significant health risks”.